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Abstract
Background: Gamma (c) oscillations (30–50 Hz) have been shown to be excessive in patients with schizophrenia (SCZ)
during working memory (WM). WM is a cognitive process that involves the online maintenance and manipulation of
information that is mediated largely by the dorsolateral prefrontal cortex (DLPFC). Repetitive transcranial magnetic
stimulation (rTMS) represents a non-invasive method to stimulate the cortex that has been shown to enhance cognition and
c oscillatory activity during WM.
Methodology and Principal Findings: We examined the effect of 20 Hz rTMS over the DLPFC on c oscillatory activity
elicited during the N-back task in 24 patients with SCZ compared to 22 healthy subjects. Prior to rTMS, patients with SCZ
elicited excessive c oscillatory activity compared to healthy subjects across WM load. Active rTMS resulted in the reduction
of frontal c oscillatory activity in patients with SCZ, while potentiating activity in healthy subjects in the 3-back, the most
difficult condition. Further, these effects on c oscillatory activity were found to be specific to the frontal brain region and
were absent in the parieto-occipital brain region.
Conclusions and Significance: We suggest that this opposing effect of rTMS on c oscillatory activity in patients with SCZ
versus healthy subjects may be related to homeostatic plasticity leading to differential effects of rTMS on c oscillatory
activity depending on baseline differences. These findings provide important insights into the neurophysiological
mechanisms underlying WM deficits in SCZ and demonstrated that rTMS can modulate c oscillatory activity that may be a
possible avenue for cognitive potentiation in this disorder.
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Introduction
Gamma (c) oscillations (30–50 Hz) are associated with working
memory (WM). WM involves the maintenance and manipulation
of information [1] and has been shown to increase c oscillations
with increases in WM load in healthy subjects [2], particularly in
the dorsolateral prefrontal cortex (DLPFC; [3]). Schizophrenia
(SCZ) patients have marked deficits in WM [4] that has been
attributed to altered c oscillatory activity. For example, we
demonstrated that SCZ patients compared to healthy subjects
elicit excessive c oscillatory activity while performing the N-back
task at all WM loads that was accompanied by impaired
performance [5]. Although previous studies provide evidence for
reduced c oscillatory activity in SCZ patients during cognitive
PLoS ONE | www.plosone.org 1 July 2011 | Volume 6 | Issue 7 | e22627control [6] and sensory oddball [7] tasks, recent findings suggest
that c oscillatory activity is excessive in the frontal cortex during
WM performance [2,5]. Excessive c oscillatory activity has also
been shown in the posterior cortex in patients with SCZ during
visual stimulation [3,8]. Altered c oscillatory activity in SCZ
patients may therefore be related to impaired WM function in this
disorder.
Animal studies have shown that c oscillations during WM are
supported by c –aminobutyric acid (GABA) interneurons in the
DLPFC [9,10,11]. Specifically, GABAergic activity may be
involved in the generation and inhibition of c oscillations [12,13,
14,15], a mechanism that has been shown to be impaired in SCZ
[16,17,18,19]. In line with these studies, Farzan et al. (2010) mea-
sured neurophysiological indices of GABAB receptor inhibition
from the DLPFC in SCZ patients compared to bipolar disordered
patients and healthy subjects through combined transcranial mag-
netic stimulation (TMS) electroencephalography (EEG) [20]. It
was demonstrated that the inhibition of c oscillations was sig-
nificantly reduced in DLPFC of SCZ patients compared to the
other 2 groups [20]. It is possible, therefore, that deficits in the
inhibition of c oscillations in the DLPFC in SCZ results in
excessive c activity as was previously reported [5], which may
contribute to WM deficits in this disorder. By contrast, in healthy
subjects it was demonstrated that repetitive TMS (rTMS) over the
DLPFC selectively enhanced c oscillatory activity that was most
pronounced in 3-back [3], which may be related to its ability to
potentiating effects on GABAergic neurotransmission [21,22].
Methods
Objective
The objective of this study was to administer high frequency
rTMS over the DLPFC to measure its effect on c oscillatory
activity during the N-back task in patients with SCZ and healthy
subjects. It was hypothesized that excessive c oscillatory activity in
patients with SCZ would be reduced with rTMS compared to
sham stimulation and in contrast to healthy subjects.
Participants
Twenty-four (males=14; females=10) patients with a diagnosis
of SCZ or schizoaffective disorder confirmed by the Structured
Clinical Interview for DSM-IV [23] and 22 (males=11; females
=11) healthy individuals participated in this study. Eighteen of the
twenty-two subjects overlapped with a study previously published
[3]. All subjects were right handed confirmed using the Oldfield
Handedness Inventory [24]. Patients with SCZ were all treated
with antipsychotic medication (14.4610.9 mg olanzapine, 6
patients; 233.36230.9 mg clozapine, 3 patients; 5.263.0 mg
risperidone, 7 patients; 733.36416.3 mg of quetiapine, 3 patients;
2.461.6 mg fluphenazine, 3 patients ; 25 mg haloperidol, 1
patient; 15 mg aripiprazole, 1 patient). Demographic data of the
subject groups are shown in Table 1. The subject groups were
similar in age (t(44)=20.754, p=0.455), but differed in education
(independent t-tests: t(44)=2.954, p,0.05; Table 1). Severity of
psychopathology was evaluated using the positive and negative
symptom scale (PANSS; [25]), scale for the assessment of negative
symptoms (SANS; [26]) and the Calgary Depression Scale (CDS;
[27]; Table 1). Exclusion criteria for all subjects included a history
of substance abuse or dependence in the last 6 months determined
through the DSM-IV, a concomitant major and unstable medical
or neurologic illness or pregnant. In healthy subjects the presence
of psychopathology was ruled out through the personality
assessment screener (PAS; Psychological Assessment Resources,
Inc).
Description of Procedures
This study was a randomized, double-blind, placebo-controlled
design. Patients with SCZ and healthy subjects were randomized
into two groups allocated to receive either active or sham rTMS
and were blind to their group assignment. Furthermore, active and
sham rTMS was administered by treatment nurses who were not
involved in any other the experimental measures or data analysis.
The clinical rater and the experimenter who analyzed and inter-
preted the data were both blind to the rTMS group assignment.
The experiment took place over two testing days. On the first day,
subjects performed the N-back test while their EEG was recorded.
One week later, rTMS was administered over the DLPFC
followed by the final testing of the N-back task. The final N-
back task was performed approximately 20 minutes following the
rTMS administration to allow for cortical plasticity to take place as
well as for the placement of the EEG cap. These two N-back
testing sessions will be referred to ‘pre’ and ‘post’ measures relative
to the rTMS administration here on in.
N-Back Task. Subjects performed the N-back task while
their EEG was recorded (STIM2, Neuroscan, U.S.A.) pre and post
rTMS. Stimuli were presented on a computer monitor one at a
time and participants were required to push one button (target) if
the present stimulus was identical to the stimulus presented ‘‘N’’
trials back; otherwise, subjects pushed a different button (non-
target). Thus, the effect of increasing cognitive demand on oscil-
latory activity was tested by varying the ‘‘N’’ in the 1-, 2- and
3-back conditions. Stimuli consisted of black capital letters
presented for 250 msec followed by a delay period of 3000 msec
during which the subject was required to respond (Figure 1). In the
1- and 2-back conditions, stimuli were presented continuously for
15 minutes and for 30 minutes in the 3-back condition. The 3-
back was administered for double the length of time to ensure a
satisfactory number of correct responses were contained for the
data analysis (Table 2). The number of target letters in each
condition was: 46 of 198 (23.2%) 1-back; 31 of 197 trials (15.7%)
2-back, and 59 of 400 trials (14.6%) 3-back condition. The N-back
task took 1 hour for subjects to complete with the order of con-
ditions randomized and counterbalanced to control for order effects.
Repetitive TMS. Repetitive TMS was administered using a
Medtronic MagPro stimulator (Medtronic, Inc., U.S.A.) with a
Table 1. Demographic Data for Healthy Subjects (HS) and
patients with schizophrenia (SCZ) and the assessment of
psychotic symptoms in patients with SCZ rTMS (6) 1 standard
deviation.
HS SCZ
Age 44.500 (6) 11.43 47.21 (6) 12.80
Age Range 23–61 23–70
Female (n) 11 10
Male (n) 11 14
PANSS Scores Positive NA 17.50 (6) 6.40
Negative NA 14.71 (6) 7.09
Global NA 27.45 (6) 7.60
Total NA 57.54 (6) 16.05
Psyrats Score Total NA 13.42 (6) 13.52
CDS Score Total NA 2.94 (6) 2.99
SANS Score Total NA 37.67 (6) 21.42
doi:10.1371/journal.pone.0022627.t001
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20 Hz, 90% resting motor threshold for 25 trains comprising of 30
pulses per train, inter-train interval of 30 seconds for a total of 750
pulses per hemisphere in accordance with published safety
guidelines [28]. The total time for the rTMS administration was
25 minutes, 12.5 minutes per hemisphere. The resting motor
threshold was defined as the lowest intensity that produced a
motor evoked potential of at least 50 mV in 50% of the trials
delivered. Sham stimulation was delivered at the same rTMS
parameters as active stimulation with the coil held in a single wing-
tilt position at 90 degrees to induce similar somatic sensations as in
the active stimulation with minimal direct brain effects. The order
of stimulation (right then left versus left then right) was also
randomized and counterbalanced to control for order effects.
DLPFC Site Localization. The localization of the DLPFC
was determined through neuronavigational techniques using
the MINIBIRD system (Ascension Technologies) combined with
MRIcro/reg software using a T1-weighted MRI scan obtained for
each subject with seven fiducial markers in place. Repetitive TMS
was targeted at the junction of the middle and anterior one-third
Figure 1. A representation of the 1-, 2- and 3-back conditions that were completed in a randomized order by patients with
schizophrenia (SCZ) and healthy subjects (HS) pre-post rTMS. Subjects were required to push one button (target) if the current letter was
identical to the letter presented ‘‘N’’ trials back; otherwise the participants pushed a different button (non-target). Correct responses for target (TC)
and non-target (NTC) were included in the data analysis (A). The timing of one trial from the presentation of a one letter separated by a (+) sign
followed by a subsequent letter for a total time of 3000 msec (B).
doi:10.1371/journal.pone.0022627.g001
Table 2. Total number (TC+NTC) of trials analyzed for healthy subjects (HS) and patients with schizophrenia (SCZ) in the 1-, 2-, and
3-back task conditions pre- post-rTMS (6) 1 standard deviation.
No of Trials Condition HS SCZ
Pre Post Pre Post
Active Sham Active Sham Active Sham Active Sham
1-Back 130.91 130.00 127.09 114.81 82.00 84.17 104.00 81.00
(±)S D 39.77 24.61 42.37 48.82 42.21 43.79 35.60 41.97
2-Back 150.00 130.36 139.82 104.91 101.92 96.08 54.42 90.50
(±)S D 32.75 33.14 43.21 26.36 42.39 44.07 36.39 45.57
3-Back 283.82 225.64 264.45 181.64 157.27 168.42 122.08 131.83
(±)S D 76.22 62.92 79.65 77.80 73.38 76.71 59.42 78.26
doi:10.1371/journal.pone.0022627.t002
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250, 30, 36) corresponding with posterior regions of Brodmann
area 9 (BA9), and overlapping with the superior region of BA46
(Figure 2). The selection of this site was based on recent meta-
analyses of functional imaging studies that examined WM and the
activation of the DLPFC [29,30,31].
EEG Measurement of Evoked c Oscillatory Acti-
vity. Evoked and induced oscillatory methods have both been
used to examine oscillatory activity elicited during WM. These two
analytical methods differ in their relationship with the stimulus
onset. Evoked oscillatory responses are phase-locked to the
stimulus onset with a fixed latency following stimulus onset and
are measured by stimulus-triggered averaging of responses in a
time domain [32]. By contrast, induced oscillatory activity is not
phase-locked to stimulus onset and appears as a jitter in latency
that varies from trial to trial, thus, these responses are cancelled
out when trials are averaged [32]. In other words, evoked re-
sponses are characterized by a constant time and phase relation-
ship with the stimulus while a loose temporal relationship with the
stimulus characterizes induced activity. In the frontal region,
evoked and induced oscillatory activities have been shown to
overlap during the N-back task [33]. Furthermore, it was initially
suggested that early evoked activities reflect perceptual processes
while induced activities reflect more attentional and WM processes
[32]. However, there is increasing evidence for the modulation of
evoked oscillatory activity with WM load particularly when longer
delay periods are examined [2,3,34] thereby suggesting that
evoked oscillations are involved in both attentional and other WM
processes (e.g., retention and retrieval) and are not simply limited
to perception. In addition, during EEG recordings both eye
movement and cranial musculature artefact have been a concern
with the measurement of oscillatory activity during cognitive
paradigms specifically in the c band. For example, Yuvel-Green-
berg et al (2008) measured microsaccadic eye movement and EEG
simultaneously while subjects performed a cognitive task and
demonstrated that induced c oscillatory activity corresponded with
microsaccadic eye movement rather than neuronal processing
[35]. It was concluded that evoked measurement of c oscillatory
activity is less susceptible to eye movement artefact owing to the
fact that this activity is cancelled out when multiple trials are
averaged. This also applies to activity from cranial musculature
which is another source of artefact that has been a concern with
the examination of c oscillatory activity during cognition [36].
That is, the modulation of c band activity has been associated with
cranial musculature as the difficulty of cognitive tasks increases.
However, it has been reported that such artefact due to cranial
musculature is characterized by irregular spikes present across
spectral frequencies [37] and therefore are more likely to influence
induced measurement of c oscillatory activity. The measurement
of evoked oscillatory activity during WM performance is less
susceptible to both eye movement and cranial musculature artefact
[38]. As such, we measured mean evoked c power from frontal
electrodes while subjects completed the N-back task before (pre)
and after (post) rTMS was administered over the right and left
DLPFC.
EEG Recording. EEG data were acquired using a 64-
electrode cap and Synamps2 DC-coupled EEG system (Com-
pumedics, U.S.A.). Four electrodes placed on the outer side of
each eye, above, and below the left eye were used to monitor eye
movement artefact. Data was recorded at a rate of 1000 Hz DC
and with a 0.3 to 200 Hz band pass hardware filter. Electrode
impedances were lowered to ,5k V. All channels were referenced
to an electrode placed posterior to the Cz electrode.
Offline EEG processing. We measured mean evoked
oscillatory power over the delay period according to published
protocol [3]. Data was filtered off-line using a 1 to 100 Hz band
pass zero phase shift filter (slope, 24 dB/oct). Epochs were defined
as 21000 to +3095 msec relative to the cue onset and were
baseline corrected with respect to the prestimulus interval (21000
to cue onset). All trials were manually inspected and any error
trials or epochs containing artefact (movement or electro-
oculogram exceeding +/250 mV) were excluded from further
analysis.
Ethics
All subjects provided their written informed consent and the
protocol was approved by the Centre for Addiction and Mental
Health in accordance with the declaration of Helsinki.
Data Analysis and Statistical Methods
Behavioural Analysis. The total number of correct trials
(target correct (TC) and non-target correct (NTC)) including those
trials rejected due to artefact were included in the data analysis for
WM performance and reaction time. Two separate repeated
measures ANOVA were conducted on the baseline measures of
WM performance and reaction time with N-back as a within-
subject factor (1- versus 2-versus 3-back) and group (patients with
SCZ versus healthy subjects) as the between-subject factor. Two
separate mixed model repeated measures (MMRM) for WM and
reaction were then performed on change score (post rTMS-pre
rTMS) with Group (patients with SCZ versus healthy subjects) and
rTMS (active versus sham) as between-subject factors and WM
load (1- versus 2- versus 3-back) as the within-subject factor with a
significance level set at p,0.05. Interaction effects were further
examined with Bonferroni-adjusted pairwise comparisons (SAS
System v.9.1.3; SAS Institute, NC, USA).
EEG Analysis. Artefact-free EEG data were imported into
MATLAB (The MathWorks, Inc. Natick, MA, USA) using the
Figure 2. Targeting the Dorsolateral Prefrontal Cortex (DLPFC)
for rTMS stimulation. Transverse view from a single subject with
exposed cortex and overlap of Brodmann areas 9 & 46, highlighted
(white) on a T1-weighted 3D MRI. Using MRI-to-MiniBird co-registration,
the centre of the TMS coil was held over this region.
doi:10.1371/journal.pone.0022627.g002
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power for each frequency band was examined using a zero phase
shift Hamming based FIR filter (in the order of 100) to decompose
the EEG signal into d (1–3.5 Hz); h (4–7 Hz); a (9–12 Hz); b (14–
28 Hz) and c, (30–50 Hz) and averaged over the delay period (0–
3000 msec from cue onset) for the target correct (TC) and non-
target correct (NTC) responses for each WM load pre and post
rTMS for each subject. Mean evoked oscillatory power was then
assessed during these responses (TC and NTC) from the frontal
electrodes (AF3, AF4, F5, F3, F1, FZ, F2, F4, and F6), and
averaged for each subject. Since spectral analysis of EEG activity is
often not normally distributed [40], the data was log transformed
prior to analysis. A series of five (across oscillatory power in the 5
frequency bands) repeated measures ANOVA were conducted at
baseline with N-back condition (1- versus 2- versus 3-back) as a
within subject factor and group (patients with SCZ versus healthy
subjects) as the between subject factor with a significance level set
at p,0.05. Next, a series of five MMRM were performed on
change score (post rTMS-pre rTMS) with Group (patients with
SCZ versus healthy subjects) and rTMS (active versus sham) as
between-subject factors and WM load (1- versus 2- versus 3-back)
as the within-subject factor with a significance level set at p,0.05.
The exclusion of the time (pre rTMS versus post rTMS) within
subject factor was chosen to simplify the model to allow for an
easier interpretation of a 3-way interaction versus a 4-way inter-
action term that would have been highly unstable. As such, the
MMRM analyses were carried out on change scores for oscillatory
power and behavioural data (post rTMS-pre rTMS). Interaction
effects were further examined with Bonferroni-adjusted pairwise
comparisons (SAS System v.9.1.3; SAS Institute, NC, USA).
MMRM analyses were therefore conducted on the change in WM
performance and oscillatory activity following rTMS as the 4-way
interaction (e.g., group (patients with SCZ versus healthy subjects),
rTMS (active versus sham) and N-back (1- versus 2- versus 3-back))
would have been unstable as directed by our biostatistician.
Subsequent exploratory analyses that were not set out as a priori
hypotheses were carried out using repeated measures ANOVAs.
Results
Baseline N-Back Performance
A repeated measures ANOVA on N-back performance pre
rTMS found a significant main effect of N-back (F(2,78)=52.29;
p=0.0001) such that performance decreased with increased WM
load across subjects. A significant group effect was also revealed
(F(1,39)=6.87; p=0.012) reflecting poorer N-back performance in
patients with SCZ compared to healthy subjects. The interaction
was not significant. A repeated measures ANOVA on response
time pre rTMS also revealed a significant main effect of N-back
(F(2,84)=29.45; p=0.0001) indicative of increased response time
with increased WM load. The group and interaction were not
significant.
Baseline Evoked c Power
Prior to rTMS, a repeated measures ANOVA on evoked c
power revealed a significant main effect of N-back (F(2,80)=4.21;
p=0.018) reflecting the increase in c power from 1- to 2-back
(t=22.61, df=43, p=0.012) with a subsequent decrease in c
power from the 2- to 3-back (t=2.37, df=42, p=0.022) found
through paired t-tests. The N-back6group interaction was also
found significant (F(2,80)=10.38; p=0.018) whereby an indepen-
dent t-test revealed reduced c power in the 3-back condition
(t=24.68, df=1,40, p=0.004). To examine if this effect was due
to a difference in performance, first an independent t-test was
conducted on 1-back performance of SCZ patients compared to
healthy subjects’ 3-back performance and found no difference
(t=21.23,df=42,p=0.226)followedbyanindependentt-testonc
power which found that patients still generated significantly greater
activity (t=23.70, df=43, p=0.001) at equivalent performance
levels. Finally, the group effect was significant (F(1,40)=9.15;
p=0.004) reflective of significantly greater c power generated by
the SCZ group compared to the healthy subject group.
EEG Spectral Analysis of Other Frequency Bands
Four separate repeated measures ANOVA conducted on the d,
h, a, and b frequency bands revealed a group effect in b power
(F(1,38)=11.68; p=0.002) such that SCZ patients generated sig-
nificantly reduced b activity compared to healthy subjects.
Change in N-Back Behavioural Performance
N-back performance accuracy was significantly worse in
patients with SCZ compared to healthy subjects pre and post
rTMS; however, there were no significant improvements in N-
back performance accuracy following either active or sham rTMS
stimulation in either subject group found through the MMRM
analysis (Table 3). Similarly, the MMRM analysis found no effect
of rTMS on response time in either subject group (Table 3).
Change in Evoked c Power
The MMRM analysis on the change in mean c power (post
rTMS c power-pre rTMS c power) found a significant Group
difference between patients with SCZ and healthy subjects
(F(1,42)=18.23; p=0.0001). Further, significant Group6rTMS
(F(1,42)=10.37; p=0.0025) and Group6N-back condition (F(2,42)
=6.41; p=0.0037) interaction effects were found. The Group6
rTMS6N-back interaction was also significant (F(2,42)=3.75; p=
0.0317; Figure 3A) indicating that the effects of Group and rTMS
differed across WM load. A series of 15 Bonferroni-adjusted
pairwise comparisons were then performed to better understand
this 3-way interaction. Active stimulation was found to reduce c
power in patients with SCZ, while potentiating c power in healthy
subjects. Moreover, this effect of active stimulation on c power
differed significantly in patients with SCZ compared to healthy
subjects in the 3-back condition (p,0.0001), while trending
differences were observed in the 1- (p=0.0750) and 2-back
(p=0.0795) conditions. To explore whether the effects of rTMS in
the 3-back condition were specific to the frontal brain region, we
compared mean c power from the frontal versus parieto-occipital
brain region (electrodes: OZ, O1, O2, PO3, and PO4). A repeated
measures ANOVA was conducted with Group, Time, and rTMS
as between subject factors and brain region as a within subject
factor (SPSS 15.0, SPSS Inc. Chicago, Illinois, USA) and a
significant Time6Region6Subject6rTMS (F(1, 35)=9.072; p=
0.005; Figure 3B) interaction was revealed. Pairwise comparisons
found no differences in the parieto-occipital brain region in both
subject groups following both active and sham stimulation. The
effects of active rTMS on c oscillatory activity therefore were
specific to the frontal brain region in the 3-back condition. These
results suggest that active rTMS over the DLPFC reduced frontal
c power in patients with SCZ, while potentiating this activity in
healthy subjects that was most pronounced in the 3-back condition
with the greatest difficulty.
Change in EEG Spectral Analysis of Other Frequency
Bands
Although c oscillatory activity is most closely associated with
higher order cognitive tasks, we explored the effect of rTMS on
rTMS and Gamma Oscillations in Schizophrenia
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rTMS power) in the other frequency bands (d, h, a, and b) with
four separate MMRM analyses. Although we observed a
significant effect of Group on the change in mean oscillatory
power in the h, a, and b frequency bands, no significant Group
6rTMS interactions were observed (Figure 4). However, there was
a significant Group6rTMS6N-back interaction found in the d
frequency band such that active rTMS reduced activity in patients
with SCZ in the 3-back condition compared to sham stimulation
(p=0.0048; Figure 4). To examine if the reduction in d power was
related to the reduction in c power, a Pearson correlation
coefficient was conducted and found significant positive relation-
ships in the 1-back (r=0.745; p=0.008) and 3-back (r=0.779;
p=0.008). No differences were found in healthy subjects in d
activation following rTMS administration.
Effect of Antipsychotic Medication
A Pearson correlation coefficient was performed to determine if
the changes in c and d oscillatory activity in the 3-back were
related to antipsychotic medication using chloropromazine equi-
valents (CPZ; [41]) in the SCZ patient group. No relationships
were found between c or d oscillatory activities and CPZ equi-
valents in the 3-back pre or post rTMS administration.
Discussion
Consistent with our previous report [3], patients with SCZ
elicited excessive frontal c and reduced frontal b oscillatory activity
compared to healthy subjects prior to rTMS. Following rTMS,
excessive frontal c oscillatory activity in SCZ patients was
significantly reduced following bilateral rTMS to DLPFC. By
contrast, rTMS significantly potentiated c oscillatory activity in
healthy subjects. These effects were most pronounced in the 3-
back and were specific to the frontal cortical regions. rTMS also
reduced d activity in patients only. These results suggest that
rTMS to DLPFC reduces excessive frontal c oscillatory activity
during the N-back in SCZ patients an effect that was opposite to
that observed in healthy subjects.
The opposing effect of rTMS on c oscillatory activity in patients
and healthy subjects may be related to differential changes in
GABAergic activity. For example, Daskalakis et al. (2006)
demonstrated that 20 Hz rTMS applied to the motor cortex in
healthy subjects had different effects depending on level of baseline
GABAergic inhibitory neurotransmission. That is, rTMS poten-
tiated short interval cortical inhibition (SICI), a neurophysiological
paradigm that is related to GABAA receptor inhibition [42], in
subjects with relatively low baseline SICI and suppressed SICI in
subjects with relatively high baseline activity [21] suggesting that
rTMS can produce variable effects on GABAA receptor mediated
inhibition depending on baseline levels. As GABAA inhibitory post
synaptic potentials are involved in generation of c oscillations
[12,13,14] such findings can be used to explain the variable effects
of rTMS on c oscillatory activity in SCZ patients and healthy
subjects. That is, rTMS inhibited c oscillatory activity in SCZ
patients with relatively greater c activity at baseline, while
potentiating activity in healthy subjects with relatively lower c
activity at baseline. Such effects may also be related to homeostatic
plasticity, a brain mechanism that maintains neuronal activity
within a useful physiological range and is critical to neuronal
stability [43]. There is considerable evidence for the role of
GABAA receptor activity in the regulation of homeostatic plasticity
[44,45,46,47,48] by modulating the number of post-synaptic
GABAA receptors that are activated to increase or decrease
inhibitory neurotransmission [46,49,50,51]. Regulation of GABAA
receptors in homeostatic plasticity have also been shown to be
involved in the synchronization of neuronal activity [52,53,54,55].
The opposing effect of rTMS on c oscillatory activity in the
current study, therefore, may reflect differential regulation of
inhibitory activity through efficacy of GABAA receptors important
in homeostatic plasticity and generation of c oscillations.
Alternatively, the effect of rTMS on c oscillatory activity may
reflect the regulation of cortical excitability to maintain homeo-
static plasticity as GABA neurons are dependent on excitatory
drive in generation of c oscillations [12,14,56,57,58]. In this
regard, the main source of neuronal excitation is through release
of glutamate which typically activates N-methyl-D-asparate
Table 3. Working memory (WM) behavioural performance (%) and reaction time (RT; msec) during the N-back in healthy subjects
(HS) versus patients with schizophrenia (SCZ) pre-post either active or sham rTMS (6) 1 standard deviation pre-post rTMS.
Behavioural Condition HS SCZ
Pre Post Pre Post
Active Sham Active Sham Active Sham Active Sham
Score (%) 1-Back 83.19 92.12 83.58 94.01 79.05 77.33 76.22 69.42
(±)S D 11.61 2.26 7.80 3.15 15.16 18.31 21.07 29.75
2-Back 74.18 88.03 72.49 89.93 66.25 72.46 62.95 79.61
(±)S D 16.29 13.57 13.32 6.87 11.58 22.99 24.11 16.72
3-Back 66.86 77.41 60.85 62.65 48.38 59.99 48.55 57.46
(±)S D 11.58 15.39 3.12 3.71 16.08 20.84 15.40 15.97
RT (msec) 1-Back 793.56 720.78 756.73 706.81 945.02 754.36 874.35 796.48
(±)S D 147.18 99.26 90.68 134.15 276.11 192.41 277.71 192.70
2-Back 924.42 891.49 861.96 861.11 1130.73 865.01 1012.17 902.22
(±)S D 257.44 272.74 204.21 216.49 434.34 245.49 340.66 288.48
3-Back 990.42 970.08 956.42 865.53 1114.51 938.66 937.35 929.60
(±)S D 317.13 247.70 257.75 203.11 277.71 236.39 322.09 252.02
doi:10.1371/journal.pone.0022627.t003
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brane [59]. The duration of non-NMDA excitatory post synaptic
potentials (EPSPs) are optimal for fast signaling and coincidence
detection. As such, non-NMDA EPSPs are important in the
precise control of spike timing needed in the synchronization of
cortical oscillations. The generation of oscillatory activity, there-
fore, may not only depend on GABA mediated inhibition but also
on the recruitment of interneuron firing by glutamate excitation
[59]. Homeostatic plasticity has been shown through the alteration
of cortical excitability with transcranial direct current stimulation
(tDCS) and rTMS administered to the motor cortex in healthy
subjects [60]. Siebner et al. (2004) demonstrated that, cathodal
tDCS reduced corticospinal excitability followed by 1 Hz rTMS
that resulted in a sustained increase in corticospinal excitability. By
contrast, increased corticospinal excitability by anodal tDCS was
subsequently reduced with 1 Hz rTMS. Those subjects with the
greatest changes induced by tDCS priming also exhibited the
greatest change in corticospinal excitability following rTMS [60].
Siebner et al. (2004) therefore demonstrate that rTMS can
produce variable effects on cortical excitability depending on base-
line activity level. Given the importance of excitatory drive on c
oscillations, the homeostatic regulation of cortical excitability
through rTMS may also have produced our finding of opposing
effects on c oscillatory in patients versus healthy subjects.
As previously shown, rTMS had no effect on the d, h, a, and b
frequency bands in healthy subjects [3], that included an overlap
of 82% of the subjects tested in the current study. In SCZ patients,
however, rTMS reduced d oscillatory activity in the 3-back
compared to sham stimulation. This finding is consistent with a
previous rTMS study in patients with SCZ with predominant
Figure 3. Mean log transformed gamma oscillatory power (c; 30–50 Hz; uV
2) for target correct (TC) and non-target correct (NTC)
responses during the N-back task pre-post rTMS in healthy subjects (HS; N=22) versus patients with schizophrenia (SCZ; N=24)
(A). Mean log transformed c oscillatory power (uV
2) for target correct (TC) and non-target correct (NTC) responses during the 3-back condition
measured from the frontal and parieto-occipitalbrain regions pre-post rTMS in patients with schizophrenia (SCZ; N=24) and healthy subjects (HS;
N=22) (B). Bars represent (6) 1 standard deviation.
doi:10.1371/journal.pone.0022627.g003
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a reduction in negative symptoms and d oscillatory activity when
rTMS was applied at 10 Hz to the left DLPFC for 5 days a [61].
Furthermore, it is possible that the reduction of d activity following
rTMS in SCZ patients observed in the current study was related to
reduction of c oscillatory activity reflecting the non-random
relationships between oscillatory frequencies [62]. That is, cross-
frequency interactions or ‘‘nesting’’ is observed when the power of
a discrete frequency band is modified by the phase of a lower
frequency band that coexists during information processing [62].
In this regard, hierarchies of nested rhythms have been observed
in the neocortex [63] between d, h, and c oscillatory activities.
These findings suggest that c oscillations are nested within d
oscillations that may explain the concomitant reduction in both
activities following rTMS.
The current study contributes to the considerable evidence
associating abnormal prefrontal functioning with WM impairment
in patients with SCZ. However, the nature of prefrontal dys-
function remains controversial. That is, previous studies have
reported similar [34], reduced [6,64] and increased [2,5] c
oscillatory activity in patients with SCZ compared to healthy
subjects while performing WM tasks. Similar divergent findings
have also been reported in fMRI studies that may be accounted for
the sensory domain of the WM tested. In this regard, Brahmbhatt
et al. (2006) tested patients with SCZ and their first degree relatives
and reported hyperactivity of the prefrontal cortex during verbal
WM while hypoactivation was observed when this task was
administered in the visual domain [65]. Alternatively, differences
in the activation of the prefrontal cortex may result from dif-
ferences in the performance levels of patients with SCZ. For
example, Callicott et al. (2003) observed both hyper- and hypo-
activation of the prefrontal cortex during the N-back task in
patients with SCZ compared to healthy subjects [66]. However,
when patients were compared in terms of performance, it was
found that low performers generated low activity while high
performers generated relatively higher activity. Furthermore,
when high performing patients were compared to high performing
healthy subjects, hyperactivation of the prefrontal cortex was
observed. Callicott et al. (2003) therefore demonstrate that at
equivalent performance levels, patients with SCZ show hyper-
activation of the prefrontal cortex that is consistent with our
previous study [5] and prior to rTMS in the current study. The
nature of prefrontal abnormalities underlying WM impairments
continues to be debated. Moreover, factors such as performance
levels, sensory domain, experimental paradigms, antipsychotic
medication and the heterogeneity in the DLPFC warrants further
examination vis a ` vis measuring c oscillatory activity during WM
in patients with SCZ.
Limitations
This study is limited in some important ways. First, although
rTMS decreased excessive c oscillatory activity in SCZ patients
and potentiated activity in healthy subjects, this change was not
related to improved WM performance and may suggest that the
relationship between c oscillatory and WM performance may be
epiphenomenal. Previous studies, however, have shown that
rTMS induced cognitive changes are either delayed or optimal
at some later time point [67,68] and that repeated rTMS sessions
may be needed to produce changes in gene expression and synapse
formation associated with changes in short-term plasticity and
cognition [69]. Nevertheless, this study provides early and
interesting neurophysiological evidence for the modulating effect
of rTMS on c oscillatory activity, a finding that warrants further
investigation as a potential therapeutic mechanism which under-
lies WM impairments in SCZ. Second, the relatively small sample
size tested may be insufficient to detect an improvement in
performance on the N-back following rTMS. Replication studies
may consider using a larger sample size to examine this relation-
ship. However, the fact that rTMS altered c oscillatory activity
compared to sham, suggests that the change in c was not related to
the small sample size. Nevertheless, such findings should be repli-
cated in a larger sample to minimize Type II error and stabilize
statistical parameter estimates [70]. Third, our finding of reduced
c oscillatory activity following rTMS may be related to the effect of
anti-psychotic medication. In this regard, Hong et al. (2004)
reported enhanced 40 Hz oscillations in SCZ patients that were
treated with second generation compared those taking conven-
tional antipsychotics [71]. In this study, oscillations were parsed
into 20, 30 and 40 Hz; however, 30–50 Hz range is most
conventionally examined during cognitive tasks [72]. Similarly, a
differential effect of antipsychotic medication on cognitive per-
formance has also been reported with SCZ patients on second
generation performing better than those patients on conventional
antipsychotics on a variety of cognitive tests, including WM
[73,74,75]. In our sample, only 4 subjects were on conventional
antipsychotics and these subjects happened to be randomly
assigned to the sham group. Nevertheless, there were no dif-
ferences found in c oscillatory activity or in WM performance pre
or post sham rTMS in those patients on conventional versus
second generation antipsychotics. We were unable therefore to
evaluate the effect of rTMS on c oscillatory activity in SCZ
patients on conventional versus second generation antipsychotics.
This study did not include measures of neurotransmitter activity or
dynamics pre or post rTMS and represents a final limitation to this
study. For example, indices of GABAergic activity have been
shown to be measured reliably through combined TMS-EEG
techniques from both motor and the DLPFC in healthy subjects
and patients with bipolar and SCZ [76,77,78] that may provide a
greater understanding of the mechanism through which rTMS
exerted the effects observed in this study. In addition, combined
rTMS-PET can be used to detect changes in the level of
extracellular dopamine [79] which could provide a better under-
standing of the action of rTMS on oscillatory activity. Future
studies measuring indices of neurotransmitter action and dynamics
through TMS-EEG or PET pre- and post-rTMS could provide a
better understanding of how rTMS exerts its action on oscillatory
activity in patients with SCZ.
Summary
In summary, we demonstrated that rTMS over DLPFC alters
frontal c oscillatory activity, with the greatest effect at higher WM
loads. In patients, rTMS reduced excessive c oscillatory activity
across WM load. In contrast, rTMS potentiated c oscillatory
activity in healthy subjects. The differential effect of rTMS on c
oscillatory activity may be related to the concept of homeostatic
plasticity involving the regulation of GABAergic inhibitory mecha-
nisms that maintain neuronal excitability within a useful phy-
siological range. These findings provide important insights into the
Figure 4. Mean log transformed oscillatory power (uV
2) for target correct (TC) and non-target correct (NTC) responses during the N-
back task pre-post rTMS in healthy subjects (HS; N=22) versus patients with schizophrenia (SCZ; N=24) across delta (d; 1–3.5 Hz),
theta (h; 4–7 Hz), alpha (a; 8–12 Hz), and beta (b; 12.5–28 Hz) frequency ranges. Bars represent (6) 1 standard deviation.
doi:10.1371/journal.pone.0022627.g004
rTMS and Gamma Oscillations in Schizophrenia
PLoS ONE | www.plosone.org 9 July 2011 | Volume 6 | Issue 7 | e22627neurophysiological mechanisms that may lead to cognitive
potentiation in this disorder.
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